Skip to main content
NeuronFeed

Generate:Biomedicines vs Parachute

Which Healthcare AI tool is better in 2026?

Generate:Biomedicines

Generative AI for programmable protein therapeutics

$700M

Parachute

Infrastructure for hospitals to monitor and deploy clinical AI

$500K

Side-by-side

Verdict

Generate:Biomedicines is the more established option (raised $700M); pricing is comparable on both sides.

Metric Generate:Biomedicines Parachute
Taglinei Generative AI for programmable protein therapeutics Infrastructure for hospitals to monitor and deploy clinical AI
Foundedi 2018🏆 2025
HQi Somerville, United States New York, US
Employeesi 1-10🏆
Neuron scorei 77🏆 49
Total fundingi $700M🏆 $500K
Latest roundi Series C · Sep 2023 Seed · Jan 2025
Valuationi
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Custom Pricing not listed
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Generate:Biomedicines and Parachute.

Capability Generate:Biomedicines Parachute
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Generate:Biomedicines

  • Has raised more capital ($700M vs $500K)
  • Higher Neuron score (77 vs 49)
  • More mature (2018)

🔵 Strengths of Parachute

  • Newer company (2025)

Which should you choose?

Choose Parachute if price matters most — it starts at Pricing not listed, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Generate:Biomedicines if you want the most established option — it has raised $700M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Generate:Biomedicines vs Parachute — which is better?

It depends on your priority. Generate:Biomedicines has raised more capital and is the more established option; Parachute has broader feature depth. See the side-by-side table above.

Is Generate:Biomedicines cheaper than Parachute?

No — Parachute's cheapest paid plan is Pricing not listed, while Generate:Biomedicines's is Custom.

Do Generate:Biomedicines and Parachute offer free plans?

Generate:Biomedicines: Paid only. Parachute: Paid only.

Contextual paths to related AI startups, deals and rankings.